Obs Flashcards
Name: Infectious disease testing (6)
- HIV
- rubella IgG
- varicella
- syphilis testing
- hepatitis B
- gonorrhoea/chlamydia
Name: Nutrition supplementation (3)
- Folic acid—0.4–1 mg OD starting at least 2–3 mo preconception until end of T1 or 5 mg OD if have FHx of NTD, current Hx IDDM, obesity, epilepsy, or Hx poor compliance
- Fe – recommended 27 mg/d for maintenance, 150–200 mg /d to treat anemia
- Prenatal multivitamins
When to do US in routine antenatal assessments according to GA?
-
8 - 12 wk : Dating U/S
- measure of crown-rump length; margin of error± 5d
-
18 - 22 wk :
- (a) anatomy and growth of fetus; margin of error ± 7 d;
- (b) placental position;
- (c) Amniotic Fluid Volume (Note: In obese women, U/S should be delayed until 21–22 wk GA)
When to do screen for gestational diabetes in routine antenatal assessments according to GA?
24 - 28wk
- Screen for gestational diabetes (GDM)—50 g oral glucose tolerance test (OGTT)
- Plasma glucose < 7.8 mmol/L → normal
- Plasma glucose > 7.8 to < 10.3 mmol/L (50g OGTT)→ do 2h 75g OGTT
- Plasma glucose > 10.3 (50 g OGTT) → GDM
- Dx of Impaired Glucose Tolerance and/or GDM
- 1–2h 75 g OGTT: 1AbN = IGT and 2+ AbN = GDM
- Fasting plasma glucose > 5.3 mmol/L
- 1 h plasma glucose (75 g OGTT) > 10.6 mmol/L
- 2 h plasma glucose (75 g OGTT) > 8.9 mmol/L
What’s normal maternal BP?
normal < 140/90 mm Hg
What’s normal FHR?
110 - 160 bpm
How to estimate date of confinement?
Naegele’s rule = (LMP+ 7d) − 3mo (for 28-d menstrual cycle)
Visible gestational sac visible at which week? (2)
- Transvaginal US: Visible gestational sac at 5 wk (b-hCG > 1,500–3,000 IU), fetal pole at 6 wk, and fetal heart beat by 6 to 7 wk
- Transabdominal U/S: 6 to 8 wk (hCG > 6,500 IU)
Name: Types of Prenatal Screening Tests (3)
- First Trimester Screening (FTS) = measures Nuchal Translucency US (NTUS) + Pregnancy-Associated Plasma Protein A (PAPP-A) + b-hCG
- QUAD = measures Maternal Serum AFP (MSAFP) + b-hCG+ unconjugated E+ inhibin A
- IPS= combines QUAD screenmarkers + NTUS + PAPP-A
What are the findings in prenatal screening tests for: Neural Tube Defect?
↑ Maternal Serum AFP (MSAFP) approximately 80% to 90% sensitivity
What are the findings in prenatal screening tests for: Trisomy 21 vs Trisomy 18?
- Trisomy 21 → ↓ MSAFP, ↑ b-hCG, ↓ unconjugated E3, ↑ inhibin
- Trisomy 18 → ↓ MSAFP, ↓ b-hCG, ↓ unconjugated E3, ↓ inhibin
Smoking is associated with ↑ risk of what? (6)
- Spontaneous abortion (1.2–1.8×)
- Abruptio placentae
- Placenta previa
- Preterm birth
- Low birth weight infant
- Sudden Infant Death Syndrome
Describe management of no/vo (4)
- Non pharmacologic: avoid spicy/greasy foods. Eat dry crackers, small frequent meals
- Pharmacologic: if causing dehydration, weight loss, and metabolic abnormalities (hyperemesis gravidarum)
- IV/P.O. hydration,
- antiemetic therapy (i.e., diclectin)
- ± nutrient supplementation
Describe management of UTI (5)
- Treat asx bacturia and uncomplicated UTI based on culture results
- Common antibiotics include: amoxicillin, Nitrofurantoin.
- Avoid TMP-SMX, especially in T1, due to antifolate effect.
- Complicated UTI or pyelonephritis: hospitalization and IV antibiotics
- ** Follow with post treatment urine culture and monthly cultures for remainder of pregnancy
Describe management of constipation (3)
- Drink ≥6–8 glasses fluid/d
- ↑ High fiber foods intake
- Exercise
Describe management: Postdates (5)
- Offer membrane stripping from 38 to 41 wk
- Expectant management until 41 + 0
- Daily fetal kick counts from 40 + 0
- Increase surveillance (Min NST, fluid assessment 2× /wk) at 41 wk
- Induction of labor between 41 and 42 GA
Name safe (5) and contraindicated (5) vaccines in pregnancy
Name indications NST (4)
- Indication: decreased FM
- Normal NST and risk factors or suspected oligo-IUGR = BPP within 24h
- Atypical or abnormal NST = urgent assessment with U/S
- Indication: pregnancies at high risk
- If stable, a normal NST generally indicates favourable outcome for 1 wek
- In IDDM or GDM, or postdate pregnancy, frequency of NST is recommended 2x/wk
Analyse results of BPP (3)
- 8/10 to 10/10 with normal fluid, 8/8 with no NST= intervention for obstetric/maternal factors
- 6/10 or 8/10 with low fluid = consult OB
- 0/10 to 4/10= immediate delivery required—consult OB
Name components of BPP (4)
Differentiate chronic vs gestational DB
Divided into chronic (Dx preceding pregnancy or diagnosed at GA < 20 wk) or gestational (Dx at GA ≥ 20 wk)
Define HTN and severe HTN
- HTN: systolic pressure > 140 mmHg or diastolic pressure > 90 mmHg on two occasions
- Severe HTN: systolic pressure ≥ 160 mm Hg ± diastolic pressure ≥ 110 mm Hg
Describe the management of HTN in pregnancy (2)
- Antihypertensives: target BP 130/80 to 155/105 mm Hg if no comorbidities
- Methyldopa, b-Blockers (Labetalol)
- IV for emergencies: Nifedipine XL, hydralazine
- Hospit: For BP > 160/110, or any adverse features
Describe timing of delivery for HTN (3)
- IOL at ≥ 37 wk for pts with preeclampsia or GHTN
- Requires OB consult
- Pts with severe preeclampsia may require earlier delivery—requires OB consult
Describe: Classification of Diabetes in Pregnancy (2)
- Preexisting diabetes (type 1 or 2)
- GDM (onset of DM during pregnancy)
- GDM is usually diagnosed in the late gestation (i.e., T2 pregnancy).
- If diagnosed before 24 wk, GA is likely undiagnosed type 2 DM. (Consider ordering an HbA1c; if elevated, more likely undiagnosed type 2 DM.)
Describe screening GDM
Describe management glycemic control and surveillance: GDM (5)
-
(A) Strict glycemic control:
- Diet control, exercise
- Insulin therapy → initiate if blood glucose not well controlled on lifestyle modification alone
- (B) Fetal surveillance:
- FM counts (6 movements in 2 hours)
- U/S to asses fetal growth/size at 36–39 wk
- If on insulin → twice weekly NST and BPP from 32 wk until delivery
Describe delivery: GDM (2)
- Recommend delivery by 41 weeks to all GDM, and by 39 weeks to IDGDM
- If EFW >4.5 kg → C/S recommended